Can-Fite BioPharma (CANF) EPS (Basic) (2014 - 2023)
Can-Fite BioPharma's (CANF) quarterly EPS (Basic) came in at -$2.23 in Q4 2023, up 56.61% YoY from -$1.43 in Q4 2022, and down 855.55% on a QoQ basis from -$0.23 in Q3 2023.
Can-Fite BioPharma (CANF) EPS (Basic) (2014 - 2023) Analysis & Trends
Can-Fite BioPharma (CANF) has 10 years of EPS (Basic) data on file, last reported at -$2.23 in Q4 2023.
- Quarterly EPS (Basic) rose 56.61% year-over-year to -$2.23 in Q4 2023, while the trailing twelve-month figure through Jun 2025 was -$1.27 (up 51.14% YoY) and the FY2025 annual result came in at -$3.7, down 763.79% from the prior year.
- EPS (Basic) fell to -$2.23 in Q4 2023, from -$0.23 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $83.25 in Q2 2020 to a low of -$360.95 in Q4 2019.
- A 5-year average of -$32.31 and a median of -$4.65 in 2022 frame the typical range for EPS (Basic).
- The widest YoY moves for EPS (Basic): up 152.98% in 2020, down 160013.18% in 2020.
- Tracing CANF's EPS (Basic) over 5 years: stood at -$360.95 in 2019, then surged by 94.91% to -$18.38 in 2020, then gained by 0.02% to -$18.38 in 2021, then jumped by 72.01% to -$5.14 in 2022, then soared by 56.61% to -$2.23 in 2023.
- The last three EPS (Basic) figures came in at -$2.23 (Q4 2023), -$0.23 (Q3 2023), and -$0.35 (Q2 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.18 |
| 10 | Can-Fite BioPharma | 2.76 Mn | -8.79 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -2.23 |
| Sep 30, 2023 | -0.23 |
| Jun 30, 2023 | -0.35 |
| Mar 31, 2023 | -0.33 |
| Dec 31, 2022 | -5.14 |
| Sep 30, 2022 | -4.78 |
| Jun 30, 2022 | -3.84 |
| Mar 31, 2022 | -4.52 |
| Dec 31, 2021 | -18.38 |
| Sep 30, 2021 | -39.92 |
| Jun 30, 2021 | 21.14 |
| Mar 31, 2021 | -5.88 |
| Dec 31, 2020 | -18.38 |
| Sep 30, 2020 | -95.94 |
| Jun 30, 2020 | 83.25 |
| Mar 31, 2020 | -32.66 |
| Dec 31, 2019 | -360.95 |
| Sep 30, 2019 | 0.06 |
| Jun 30, 2019 | -157.13 |
| Mar 31, 2019 | 0.05 |